News Minimalist logo

EMA rejects Alzheimer’s drug Leqembi over safety concerns

Financial Times — July 26, 2024, 03:00 PM UTC

Summary: The European Medicines Agency has rejected the Alzheimer’s drug Leqembi, developed by Eisai and Biogen, due to concerns over rare brain swelling side effects. The committee's decision follows the drug's approval in the US, where it is projected to generate $154 million in revenue this year. Approximately 50 million people globally are affected by Alzheimer’s, with 6.9 million in the EU.

Full article

Article metrics

The article metrics are deprecated.

I'm replacing the original 8-factor scoring system with a new and improved one. It doesn't use the original factors and gives much better significance scores.

Timeline:

  1. [4.8]
    EMA approves 14 medicines, rejects Alzheimer’s drug Leqembi (EURACTIV)
    40d 7h
    Source
  2. [3.6]
    CervoMed presents promising DLB biomarker data at AAIC 2024 (globenewswire.com)
    40d 11h
    Source
  3. [3.9]
    Anavex's drug slowed cognitive decline in early Alzheimer's trial (seekingalpha.com)
    40d 20h
    Source
  4. [4.4]
    Eisai shares drop 12% after EU rejects Alzheimer’s drug (news.yahoo.com)
    40d 22h
    Source
  5. [3.8]
    Blarcamesine significantly slows Alzheimer's decline, safe for patients (globenewswire.com)
    41d 2h
    Source
  6. [5.2]
    EU rejects Alzheimer's drug lecanemab over safety concerns (bbc.com)
    43d 6h

    ScoresSource
  7. [3.1]
    EU rejects Alzheimer's drug lecanemab over serious side effects (thesun.co.uk)
    43d 7h
    Source
  8. [4.3]
    European regulator rejects Alzheimer's drug Leqembi due to risks (cnbc.com)
    43d 10h
    Source
  9. [3.3]
    Eisai to request re-examination of lecanemab's negative CHMP opinion (prnewswire.com)
    43d 11h
    Source
  10. [3.5]
    European regulators issue negative opinion on lecanemab approval (globenewswire.com)
    43d 12h
    Source
  11. [3.5]
    CHMP issues negative opinion on lecanemab for Alzheimer's treatment (prnewswire.com)
    43d 12h
    Source